Historial de carrera de Robert F. McCullough
Antiguos cargos conocidos de Robert F. McCullough.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Summitcrest Capital, Inc.
Summitcrest Capital, Inc. Investment ManagersFinance Summitcrest Capital, Inc. provides investment advisory services. | Presidente | 01/10/2003 | - |
Presidio Management | Corporate Officer/Principal | 01/04/1999 | 01/07/2003 |
CytoCore, Inc.
CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Director Ejecutivo | 01/09/2005 | 03/04/2014 |
Presidente | 07/01/2010 | - | |
Director Financiero/CFO | 01/09/2005 | - |
Estadísticas
Internacional
Estados Unidos | 4 |
Operativa
Chief Executive Officer | 1 |
Chairman | 1 |
Director of Finance/CFO | 1 |
Sectorial
Health Technology | 2 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
CytoCore, Inc.
CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Health Technology |
Presidio Management | |
Summitcrest Capital, Inc.
Summitcrest Capital, Inc. Investment ManagersFinance Summitcrest Capital, Inc. provides investment advisory services. | Finance |
- Bolsa de valores
- Insiders
- Robert F. McCullough
- Experiencia